Skip to main content

Table 1 Population features

From: High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes

  Overall
n = 30
No CVD
n = 16
CVD
n = 14
p value between CVD status
Gender, males/females 14/16 6/10 8/6 0.210
Age, years 64 [59–71] 62 [59–68] 68 [64–73] 0.257
Disease duration, years 56 [51–62] 55 [51–60] 56 [52–64] 0.333
BMI, kg/m2 26.1 [22.9–28.9] 26.3 [22.4–28.1] 26.1 [23.9–30.1] 0.863
Waist to hip ratio 0.9 [0.8–0.9] 0.9 [0.8–0.9] 0.9 [0.8–0.9] 1.000
Insulin dose, IU/kg 0.45 [0.38–0.58] 0.46 [0.41–0.58] 0.44 [0.36–0.54] 0.830
eGFR, ml/min/1.73 m2 86.8 [60.0–95.6] 92.0 [72.0–96.4] 69.5 [53.0–90.4] 0.093
HbA1c, % 6.9 [6.6–7.3] 6.9 [6.3–7.4] 6.9 [6.6–7.2] 0.922
Total cholesterol, mg/dl 152 [140–167] 160 [140–176] 146 [123–157] 0.275
Triglycerides, mg/dl 63 [46–80] 60 [45–75] 65 [50–86] 0.236
HDL-c, mg/dl 64 [52–76] 65 [55–85] 61 [45–71] 0.091
LDL-c, mg/dl 68 [61–86] 69 [63–90] 67 [60–85] 0.901
Triglycerides/HDL ratio 1.00 [0.64–1.34] 0.80 [0.56–1.33] 1.15 [0.72–1.43] 0.155
Corrected calcium, mg/dl 9.0 [8.8–9.2] 9.0 [8.8–9.3] 9.0 [8.8–9.1] 0.956
25-OH vitamin D, ng/ml 40 [31–44] 40 [29–46] 40 [32–44] 0.906
Alkaline phosphatase, U/l 62 [46–81] 59 [52–83] 66 [45–78] 0.921
hsCRP, mg/dl 0.14 [0.10–0.26] 0.13 [0.10–0.37] 0.15 [0.10–0.24] 0.630
  1. Values are median [Q1–Q3] for continuous variables and numbers for categorical variables
  2. CVD cardiovascular disease, BMI body mass index, eGFR estimated glomerular filtration rate, HDL-c high density lipoprotein cholesterol, LDL-c low density lipoprotein cholesterol, hsCRP high sensitivity C-reactive protein